Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-07-06KROS3Power of Attorney for Keros Therapeutics, Inc. - Anne PrenerMEDIUM
This filing details a Power of Attorney granted by Anne Prener, a director of Keros Therapeutics, Inc. (KROS), to Jasbir Seehra, Keith Regnante, and Esther Cho. The attorneys-in-fact are authorized to execute and submit Forms 3, 4, and 5 to the SEC on behalf of Ms. Prener, as required by Section 16(a) of the Securities...
Micro CapBiotechnology
2026-07-06BYSI3Form 3 Filing for BeyondSpring Inc. - Ownership ChangeMEDIUM
This filing reports a change in beneficial ownership for Min Qiu, the Chief Executive Officer of BeyondSpring Inc. (BYSI). The report indicates that following a transaction, Min Qiu owns 2498 ordinary shares directly. The filing is made as of July 1, 2026, with the signature date of July 6, 2026....
Nano CapBiotechnology
2026-07-06ATRA3Initial Statement of Beneficial Ownership - Kevin G. Sarney
Kevin G. Sarney, the Interim CFO of Atara Biotherapeutics, Inc. (ATRA), has filed an Initial Statement of Beneficial Ownership (Form 3). The filing, dated June 26, 2026, indicates that Mr. Sarney directly owns no securities in the company. The document was signed on July 6, 2026....
Micro CapBiotechnology
2026-07-06ABCL3Initial Statement of Beneficial Ownership of Securities
This filing reports an initial statement of beneficial ownership of securities for Lynn Seely, a director at AbCellera Biologics Inc. The filing, dated June 30, 2026, indicates that Seely has no direct or indirect ownership of securities as of the reporting date. The document was filed by Tryn Stimart, acting as attorn...
Small CapBiotechnology